TY - JOUR
T1 - Mechanism-Driven Modeling to Aid Non-invasive Monitoring of Cardiac Function via Ballistocardiography
AU - Zaid, Mohamed
AU - Sala, Lorenzo
AU - Ivey, Jan R.
AU - Tharp, Darla L.
AU - Mueller, Christina M.
AU - Thorne, Pamela K.
AU - Kelly, Shannon C.
AU - Silva, Kleiton Augusto Santos
AU - Amin, Amira R.
AU - Ruiz-Lozano, Pilar
AU - Kapiloff, Michael S.
AU - Despins, Laurel
AU - Popescu, Mihail
AU - Keller, James
AU - Skubic, Marjorie
AU - Ahmad, Salman
AU - Emter, Craig A.
AU - Guidoboni, Giovanna
N1 - Publisher Copyright:
Copyright © 2022 Zaid, Sala, Ivey, Tharp, Mueller, Thorne, Kelly, Silva, Amin, Ruiz-Lozano, Kapiloff, Despins, Popescu, Keller, Skubic, Ahmad, Emter and Guidoboni.
PY - 2022
Y1 - 2022
N2 - Left ventricular (LV) catheterization provides LV pressure-volume (P-V) loops and it represents the gold standard for cardiac function monitoring. This technique, however, is invasive and this limits its applicability in clinical and in-home settings. Ballistocardiography (BCG) is a good candidate for non-invasive cardiac monitoring, as it is based on capturing non-invasively the body motion that results from the blood flowing through the cardiovascular system. This work aims at building a mechanistic connection between changes in the BCG signal, changes in the P-V loops and changes in cardiac function. A mechanism-driven model based on cardiovascular physiology has been used as a virtual laboratory to predict how changes in cardiac function will manifest in the BCG waveform. Specifically, model simulations indicate that a decline in LV contractility results in an increase of the relative timing between the ECG and BCG signal and a decrease in BCG amplitude. The predicted changes have subsequently been observed in measurements on three swine serving as pre-clinical models for pre- and post-myocardial infarction conditions. The reproducibility of BCG measurements has been assessed on repeated, consecutive sessions of data acquisitions on three additional swine. Overall, this study provides experimental evidence supporting the utilization of mechanism-driven mathematical modeling as a guide to interpret changes in the BCG signal on the basis of cardiovascular physiology, thereby advancing the BCG technique as an effective method for non-invasive monitoring of cardiac function.
AB - Left ventricular (LV) catheterization provides LV pressure-volume (P-V) loops and it represents the gold standard for cardiac function monitoring. This technique, however, is invasive and this limits its applicability in clinical and in-home settings. Ballistocardiography (BCG) is a good candidate for non-invasive cardiac monitoring, as it is based on capturing non-invasively the body motion that results from the blood flowing through the cardiovascular system. This work aims at building a mechanistic connection between changes in the BCG signal, changes in the P-V loops and changes in cardiac function. A mechanism-driven model based on cardiovascular physiology has been used as a virtual laboratory to predict how changes in cardiac function will manifest in the BCG waveform. Specifically, model simulations indicate that a decline in LV contractility results in an increase of the relative timing between the ECG and BCG signal and a decrease in BCG amplitude. The predicted changes have subsequently been observed in measurements on three swine serving as pre-clinical models for pre- and post-myocardial infarction conditions. The reproducibility of BCG measurements has been assessed on repeated, consecutive sessions of data acquisitions on three additional swine. Overall, this study provides experimental evidence supporting the utilization of mechanism-driven mathematical modeling as a guide to interpret changes in the BCG signal on the basis of cardiovascular physiology, thereby advancing the BCG technique as an effective method for non-invasive monitoring of cardiac function.
UR - http://www.scopus.com/inward/record.url?scp=85160091765&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85160091765&partnerID=8YFLogxK
U2 - 10.3389/fmedt.2022.788264
DO - 10.3389/fmedt.2022.788264
M3 - Article
AN - SCOPUS:85160091765
SN - 2673-3129
VL - 4
JO - Frontiers in Medical Technology
JF - Frontiers in Medical Technology
M1 - 788264
ER -